Canada - English - Health Canada

pro doc limitee - propafenone hydrochloride - tablet - 150mg - propafenone hydrochloride 150mg - class ic antiarrythmics

Canada - English - Health Canada

pro doc limitee - propafenone hydrochloride - tablet - 300mg - propafenone hydrochloride 300mg - class ic antiarrythmics

Canada - English - Health Canada

nu-pharm inc - propafenone hydrochloride - tablet - 150mg - propafenone hydrochloride 150mg - class ic antiarrythmics

United States - English - NLM (National Library of Medicine)

rebel distributors corp - propafenone (unii: 68iqx3t69u) (propafenone - unii:68iqx3t69u) - propafenone 325 mg - propafenone extended release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation in patients without structural heart disease. the use of propafenone er capsules in patients with permanent atrial fibrillation or in patients exclusively with atrial flutter or psvt has not been evaluated. propafenone er capsules should not be used to control ventricular rate during atrial fibrillation. the effect of propafenone er capsules on mortality has not been determined (see black box warnings ). propafenone er capsules are contraindicated in the presence of congestive heart failure, cardiogenic shock, sinoatrial, atrioventricular and intraventricular disorders of impulse generation or conduction (e.g., sick sinus node syndrome, atrioventricular block) in the absence of an artificial pacemaker, bradycardia, marked hypotension, bronchospastic disorders, electrolyte imbalance, or hypersensitivity to the drug.